MedPath

Wine Consumption and Glycemic Control

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: Alcohol consumption
Registration Number
NCT02518334
Lead Sponsor
University of Missouri-Columbia
Brief Summary

Many studies have reported that alcoholic beverage consumption, especially in the form of wine, reduces the risk of developing type 2 diabetes by as much as 40%. This association suggests that wine consumption may somehow improve the body's ability to control its blood glucose concentration. Indeed, it has been reported that when wine is consumed immediately prior to ingestion of glucose, the release of insulin is enhanced and blood glucose concentration is lowered. The mechanism of wine's effects on blood glucose concentration is unknown, but is likely related to its ethanol or antioxidant content. In this study, the investigators plan to test whether wine or plain ethanol (vodka) ingestion alters the control of blood glucose in subjects who have diabetes or pre-diabetes.

Detailed Description

Our central hypothesis is that improvement in glycemic control by acute consumption of wine is mediated by ethanol. Subjects will have type 2 diabetes, pre-diabetes, and be sedentary and obese (BMI \>30). Subjects' glycemic control will be assessed by an oral glucose tolerance test (OGTT) at three different time points. One OGTT will occur shortly after consumption of red wine, the second after consumption of vodka containing the identical amount of ethanol as the wine treatment, and the third OGTT will occur shortly after consumption of an equal volume of water. The three OGTTs will be administered in random order.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • insulin resistant: diagnosed with pre-diabetes or fasting blood glucose >/= 97 mg/dL
  • T2D: diagnosed by primary care physician
  • at risk of type 2 diabetes (obesity and physically inactive)
  • age: 21-65
Exclusion Criteria
  • smoking
  • insulin use (other than once daily)
  • physically active (>30 mins aerobic exercise two days/week)
  • recent (>3 mo) changes in medication use or dose
  • uncontrolled type two diabetes (HbA1C >10%)
  • advanced retinopathy or neuropathy
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Alcohol consumptionAlcohol consumptionAlcohol consumption and wine consumption
Primary Outcome Measures
NameTimeMethod
Oral glucose tolerance test3 weeks

Measurement of blood glucose taken every 15 minutes over a course of three hours.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Missouri

🇺🇸

Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath